U.S. TREASURY SECRETARY BESSENT SAYS IRAN IS NOT ABLE TO GET DOLLARS AND FUNDING FOR ITS PROXIES IS GOING DOWN
β€1π1
U.S. TREASURY SECRETARY BESSENT SAYS HE DOES NOT THINK AI BORROWING IS PROBLEMATIC AT ALL AND DOES NOT SEE WIDENING SPREADS ON AI-ISSUER DEBT AS PROBLEMATIC, ADDING THE U.S. IS STILL SEEING DEALS GET DONE AND THAT META IS FINANCING WITH EQUITY
FED'S WARSH: WE'VE DECIDED TO CHANGE FOMC SCHEDULE NEXT FALL
8 MEETINGS IS RIGHT NUMBER A YEAR
ONE MEETING WILL NOT HAVE A VOTE ON POLICY RATE
ONE MEETING WILL BE FOCUSED ON STRATEGY
FED'S WARSH: EXPECT IN 2028 TO HAVE 6 POLICY-SETTING MEETINGS
8 MEETINGS IS RIGHT NUMBER A YEAR
ONE MEETING WILL NOT HAVE A VOTE ON POLICY RATE
ONE MEETING WILL BE FOCUSED ON STRATEGY
FED'S WARSH: EXPECT IN 2028 TO HAVE 6 POLICY-SETTING MEETINGS
β€1
Sectors To Watch
Power Stocks-Power demand surges 21% YoY in October till 25th, aided by low base
DCM Shriram, Chemplast, DCW-Recommendation for Duty on PVC Resin Imports from China
Apollo Hospitals Medanta Max Healthcare Artemis HCG-(Negative)-NPPA revises prices of 543 anti-cancer drug formulations
Shakti Pumps, Tiger Logistics, Aurum PropTech-Promoter buying
Q2 Earnings-Good-Bandhan Bank, Satin Credit, Sudeep Pharma, Meesho, Gokul Agro, Gulf Oil, Aeroflex , IIFL Capital, TVS Holdings, Elantas Beck, OneEMI Tech, ACME Solar, Infobeans, RR Kabel
Power Stocks-Power demand surges 21% YoY in October till 25th, aided by low base
DCM Shriram, Chemplast, DCW-Recommendation for Duty on PVC Resin Imports from China
Apollo Hospitals Medanta Max Healthcare Artemis HCG-(Negative)-NPPA revises prices of 543 anti-cancer drug formulations
Shakti Pumps, Tiger Logistics, Aurum PropTech-Promoter buying
Q2 Earnings-Good-Bandhan Bank, Satin Credit, Sudeep Pharma, Meesho, Gokul Agro, Gulf Oil, Aeroflex , IIFL Capital, TVS Holdings, Elantas Beck, OneEMI Tech, ACME Solar, Infobeans, RR Kabel
β€1
STOCKS WATCHLIST
POSITIVE
Titagarh Rail Systems-Rs 1,717 cr wagon order from Railways Ministry
Fortis Health-Acquires 110-bedded Bengaluru Hospital for Rs 277 Cr
Polycab-MSCI defers exclusion
Hexaware Tech- Vivek Jetley appointed CEO
Infosys- Order from Canada's UNI Financial
Subros-Sets up greenfield Mfg plant in Haryana
Awfis Space-Launches 1.45 Lk Sq Ft of premium workspace
EPACK Prefab Tech-Commences commercial production at Rajasthan
Shakti Pumps, Tiger Logistics, Aurum PropTech-Promoter buying
NEGATIVE
Apollo Hospitals, Medanta, Max Healthcare-Anti-cancer drug price cuts
HD Fire Protect-Maharashtra Pollution Control Board adverse ruling
A-one Steels, Moneyview, Armee Infotech-Lockin Expiry
POSITIVE
Titagarh Rail Systems-Rs 1,717 cr wagon order from Railways Ministry
Fortis Health-Acquires 110-bedded Bengaluru Hospital for Rs 277 Cr
Polycab-MSCI defers exclusion
Hexaware Tech- Vivek Jetley appointed CEO
Infosys- Order from Canada's UNI Financial
Subros-Sets up greenfield Mfg plant in Haryana
Awfis Space-Launches 1.45 Lk Sq Ft of premium workspace
EPACK Prefab Tech-Commences commercial production at Rajasthan
Shakti Pumps, Tiger Logistics, Aurum PropTech-Promoter buying
NEGATIVE
Apollo Hospitals, Medanta, Max Healthcare-Anti-cancer drug price cuts
HD Fire Protect-Maharashtra Pollution Control Board adverse ruling
A-one Steels, Moneyview, Armee Infotech-Lockin Expiry
β€1
CITI ON JSW ENERGY
β’ Rating: BUY | Target Price: βΉ650
β’ Q2 EBITDA β21% YoY, beating estimates by 16%.
β’ Power generation β17% YoY.
β’ Strong merchant realisations continue to support profitability.
β’ Renewable capacity additions expected to drive future growth.
β’ Transmission constraints and higher interest costs remain key risks.
β’ Rating: BUY | Target Price: βΉ650
β’ Q2 EBITDA β21% YoY, beating estimates by 16%.
β’ Power generation β17% YoY.
β’ Strong merchant realisations continue to support profitability.
β’ Renewable capacity additions expected to drive future growth.
β’ Transmission constraints and higher interest costs remain key risks.
β€1
JEFFERIES ON CHOLA FINANCE
β’ Rating: BUY | Target Price: βΉ1,960 (Earlier βΉ2,100)
β’ Q2 PAT βΉ1,630 Cr β41% YoY, beating estimates by 3%.
β’ AUM βΉ2.48 lakh Cr β25% YoY.
β’ Improved asset quality supports the business outlook.
β’ Higher funding costs continue to pressure NIMs.
β’ FY27 AUM growth guidance retained at 22β23%.
β’ Rating: BUY | Target Price: βΉ1,960 (Earlier βΉ2,100)
β’ Q2 PAT βΉ1,630 Cr β41% YoY, beating estimates by 3%.
β’ AUM βΉ2.48 lakh Cr β25% YoY.
β’ Improved asset quality supports the business outlook.
β’ Higher funding costs continue to pressure NIMs.
β’ FY27 AUM growth guidance retained at 22β23%.
NUVAMA ON ADANI PORTS
β’ Rating: BUY | Target Price: βΉ2,170 (Earlier βΉ2,000)
β’ Q2 Revenue β24% YoY, EBITDA β25% YoY and Adjusted PAT β13% YoY, beating estimates.
β’ International Ports EBITDA β236% YoY.
β’ Domestic Ports Revenue β13% YoY.
β’ EBITDA estimates raised by 4% for FY27 and 2% for FY28.
β’ Higher guidance and capacity expansion support future growth.
β’ Rating: BUY | Target Price: βΉ2,170 (Earlier βΉ2,000)
β’ Q2 Revenue β24% YoY, EBITDA β25% YoY and Adjusted PAT β13% YoY, beating estimates.
β’ International Ports EBITDA β236% YoY.
β’ Domestic Ports Revenue β13% YoY.
β’ EBITDA estimates raised by 4% for FY27 and 2% for FY28.
β’ Higher guidance and capacity expansion support future growth.
CITI ON TVS MOTOR
β’ Rating: SELL | Target Price: βΉ3,600 (Earlier βΉ3,500)
β’ Q2 Revenue β44% YoY; EBITDA β47% YoY, beating estimates.
β’ Higher realisations and PLI incentives offset rising operating costs.
β’ Potential consumer finance business demerger could unlock value.
β’ Elevated valuations remain a key concern despite strong earnings growth.
β’ Rating: SELL | Target Price: βΉ3,600 (Earlier βΉ3,500)
β’ Q2 Revenue β44% YoY; EBITDA β47% YoY, beating estimates.
β’ Higher realisations and PLI incentives offset rising operating costs.
β’ Potential consumer finance business demerger could unlock value.
β’ Elevated valuations remain a key concern despite strong earnings growth.
MACQUARIE ON TVS MOTOR
β’ Rating: OUTPERFORM | Target Price: βΉ4,325
β’ Q2 EBITDA βΉ2,220 Cr β47% YoY, beating estimates by 5%.
β’ EBITDA Margin expanded to 13% despite commodity cost pressures.
β’ Consumer finance business demerger expected to unlock value.
β’ Additional capacity expansion expected to support future growth.
β’ Rating: OUTPERFORM | Target Price: βΉ4,325
β’ Q2 EBITDA βΉ2,220 Cr β47% YoY, beating estimates by 5%.
β’ EBITDA Margin expanded to 13% despite commodity cost pressures.
β’ Consumer finance business demerger expected to unlock value.
β’ Additional capacity expansion expected to support future growth.
JEFFERIES ON TVS MOTOR
β’ Rating: BUY | Target Price: βΉ5,425
β’ Q2 EBITDA and PAT β47β48% YoY, beating estimates.
β’ Sales Volumes β27% YoY.
β’ EBITDA Margin improved to 13%.
β’ Domestic two-wheeler market share reached a 23-year high of 20%.
β’ Strong export momentum continues.
β’ Rating: BUY | Target Price: βΉ5,425
β’ Q2 EBITDA and PAT β47β48% YoY, beating estimates.
β’ Sales Volumes β27% YoY.
β’ EBITDA Margin improved to 13%.
β’ Domestic two-wheeler market share reached a 23-year high of 20%.
β’ Strong export momentum continues.
JPMORGAN ON HERO MOTOCORP
β’ Rating: OVERWEIGHT | Target Price: βΉ6,845
β’ Q2 Revenue β21% YoY; EBITDA β8% YoY, beating estimates.
β’ EBITDA Margin at 13.4%.
β’ Adjusted Net Profit β5% YoY, missing estimates.
β’ Better gross margins support earnings despite cost pressures.
β’ Commodity costs and future growth outlook remain key factors to monitor.
β’ Rating: OVERWEIGHT | Target Price: βΉ6,845
β’ Q2 Revenue β21% YoY; EBITDA β8% YoY, beating estimates.
β’ EBITDA Margin at 13.4%.
β’ Adjusted Net Profit β5% YoY, missing estimates.
β’ Better gross margins support earnings despite cost pressures.
β’ Commodity costs and future growth outlook remain key factors to monitor.
JEFFERIES ON NSE
β’ Rating: BUY | Target Price: βΉ2,085
β’ Revenue expected to grow at 15% CAGR over FY27β29.
β’ EPS expected to grow at 16% CAGR over FY27β29.
β’ New business opportunities could add 15% to FY30 EPS.
β’ Strong market leadership and business diversification support growth.
β’ Improving margins, diversification and market leadership justify premium valuations.
β’ Rating: BUY | Target Price: βΉ2,085
β’ Revenue expected to grow at 15% CAGR over FY27β29.
β’ EPS expected to grow at 16% CAGR over FY27β29.
β’ New business opportunities could add 15% to FY30 EPS.
β’ Strong market leadership and business diversification support growth.
β’ Improving margins, diversification and market leadership justify premium valuations.
JEFFERIES ON ADANI ENTERPRISES
β’ Rating: BUY | Target Price: βΉ3,830
β’ Q2 EBITDA β62% YoY, beating estimates, driven by strong airports and copper businesses.
β’ Airports EBITDA β55% YoY despite a 6% decline in passenger traffic.
β’ FY27 EBITDA estimates raised by 4%.
β’ Data centre expansion provides strong long-term growth visibility.
β’ Rating: BUY | Target Price: βΉ3,830
β’ Q2 EBITDA β62% YoY, beating estimates, driven by strong airports and copper businesses.
β’ Airports EBITDA β55% YoY despite a 6% decline in passenger traffic.
β’ FY27 EBITDA estimates raised by 4%.
β’ Data centre expansion provides strong long-term growth visibility.
JEFFERIES ON BANDHAN BANK
β’ Rating: BUY | Target Price: βΉ200 (Earlier βΉ240)
β’ Q2 Net Profit β456% YoY; Net Loans β15% YoY.
β’ NII β14% YoY.
β’ Deposits β9% YoY, lagging loan growth.
β’ Higher credit costs and regulatory changes pose risks to profitability.
β’ FY28β29 earnings estimates cut by 3β4%.
β’ Attractive valuations expected to limit downside.
β’ Rating: BUY | Target Price: βΉ200 (Earlier βΉ240)
β’ Q2 Net Profit β456% YoY; Net Loans β15% YoY.
β’ NII β14% YoY.
β’ Deposits β9% YoY, lagging loan growth.
β’ Higher credit costs and regulatory changes pose risks to profitability.
β’ FY28β29 earnings estimates cut by 3β4%.
β’ Attractive valuations expected to limit downside.
JEFFERIES ON UNITED SPIRITS
β’ Rating: HOLD | Target Price: βΉ1,560
β’ Growth remains underwhelming, with weak volume momentum.
β’ Prestige & Above segment volumes β1% YoY.
β’ Gross margin expanded 88 bps.
β’ Higher advertising expenditure weighed on EBITDA margin.
β’ Persistent market headwinds in Maharashtra continue to impact growth.
β’ Strong cash flow generation provides financial comfort.
β’ Rating: HOLD | Target Price: βΉ1,560
β’ Growth remains underwhelming, with weak volume momentum.
β’ Prestige & Above segment volumes β1% YoY.
β’ Gross margin expanded 88 bps.
β’ Higher advertising expenditure weighed on EBITDA margin.
β’ Persistent market headwinds in Maharashtra continue to impact growth.
β’ Strong cash flow generation provides financial comfort.
JEFFERIES ON GMR AIRPORTS
β’ Rating: BUY | Target Price: βΉ135
β’ Q2 EBITDA β2% YoY to βΉ1,480 Cr despite higher revenue.
β’ Passenger traffic β1.4% YoY, with Hyderabad and Goa airports witnessing weak growth.
β’ Non-aeronautical revenue β17% YoY.
β’ Improving revenue yields helped offset muted passenger traffic growth.
β’ Higher revenue failed to translate into EBITDA growth.
β’ Rating: BUY | Target Price: βΉ135
β’ Q2 EBITDA β2% YoY to βΉ1,480 Cr despite higher revenue.
β’ Passenger traffic β1.4% YoY, with Hyderabad and Goa airports witnessing weak growth.
β’ Non-aeronautical revenue β17% YoY.
β’ Improving revenue yields helped offset muted passenger traffic growth.
β’ Higher revenue failed to translate into EBITDA growth.
JEFFERIES ON HERO MOTOCORP
β’ Rating: HOLD | Target Price: βΉ6,000
β’ Q2 EBITDA β8% YoY, in line with estimates.
β’ Sales volumes β11% YoY.
β’ EBITDA margin remained flat QoQ at 13.4%.
β’ Net Profit β5% YoY, missing estimates by 4% due to lower financial income.
β’ EBITDA growth remained below volume growth.
β’ Rating: HOLD | Target Price: βΉ6,000
β’ Q2 EBITDA β8% YoY, in line with estimates.
β’ Sales volumes β11% YoY.
β’ EBITDA margin remained flat QoQ at 13.4%.
β’ Net Profit β5% YoY, missing estimates by 4% due to lower financial income.
β’ EBITDA growth remained below volume growth.
GOLDMAN SACHS ON INFO EDGE
β’ Rating: BUY | Target Price: βΉ1,430 (Earlier βΉ1,410)
β’ Q2 EBITDA β29% YoY despite a challenging recruitment environment.
β’ AI products contribute a high-single-digit share of recruitment revenue.
β’ Hitesh Oberoi to step down as MD & CEO in December.
β’ Sanjeev Bikhchandani to take charge following the leadership transition.
β’ Rating: BUY | Target Price: βΉ1,430 (Earlier βΉ1,410)
β’ Q2 EBITDA β29% YoY despite a challenging recruitment environment.
β’ AI products contribute a high-single-digit share of recruitment revenue.
β’ Hitesh Oberoi to step down as MD & CEO in December.
β’ Sanjeev Bikhchandani to take charge following the leadership transition.
CITI ON CHOLA FINANCE
β’ Rating: BUY | Target Price: βΉ2,100
β’ Q2 Disbursements β45% YoY, indicating strong lending momentum.
β’ AUM β25% YoY, supported by strong loan demand.
β’ Credit costs moderated to 1.4%, indicating improving asset quality.
β’ NIM declined 30 bps QoQ.
β’ FY27 AUM growth guidance retained at 22β24%.
β’ Asset quality remains resilient despite margin pressure.
β’ Rating: BUY | Target Price: βΉ2,100
β’ Q2 Disbursements β45% YoY, indicating strong lending momentum.
β’ AUM β25% YoY, supported by strong loan demand.
β’ Credit costs moderated to 1.4%, indicating improving asset quality.
β’ NIM declined 30 bps QoQ.
β’ FY27 AUM growth guidance retained at 22β24%.
β’ Asset quality remains resilient despite margin pressure.